FR3108502B1 - Dérivés de nicotinamide mononucléotides dans le traitement et la prévention des infections bactériennes - Google Patents

Dérivés de nicotinamide mononucléotides dans le traitement et la prévention des infections bactériennes Download PDF

Info

Publication number
FR3108502B1
FR3108502B1 FR2003085A FR2003085A FR3108502B1 FR 3108502 B1 FR3108502 B1 FR 3108502B1 FR 2003085 A FR2003085 A FR 2003085A FR 2003085 A FR2003085 A FR 2003085A FR 3108502 B1 FR3108502 B1 FR 3108502B1
Authority
FR
France
Prior art keywords
prevention
treatment
bacterial infections
nicotinamide mononucleotide
mononucleotide derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2003085A
Other languages
English (en)
Other versions
FR3108502A1 (fr
Inventor
Guillaume Bermond
Laurent Garçon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvamid SA
Original Assignee
Nuvamid SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR2003085A priority Critical patent/FR3108502B1/fr
Application filed by Nuvamid SA filed Critical Nuvamid SA
Priority to CA3171744A priority patent/CA3171744A1/fr
Priority to US17/914,576 priority patent/US20230210881A1/en
Priority to JP2022558101A priority patent/JP2023526726A/ja
Priority to PCT/EP2021/057938 priority patent/WO2021191422A1/fr
Priority to CN202180033681.XA priority patent/CN115697349A/zh
Priority to AU2021245030A priority patent/AU2021245030A1/en
Priority to EP21713440.2A priority patent/EP4125929A1/fr
Publication of FR3108502A1 publication Critical patent/FR3108502A1/fr
Application granted granted Critical
Publication of FR3108502B1 publication Critical patent/FR3108502B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

DÉRIVÉS DE NICOTINAMIDE MONONUCLÉOTIDES DANS LE TRAITEMENT ET LA PRÉVENTION DES INFECTIONS BACTÉRIENNES La présente invention concerne un composé de formule (I) ou un sel et/ou solvate pharmaceutiquement acceptable de celui-ci ; (I) dans lequel X, R1, R2, R3, R4, R5, R6, R7, R8, Y, et sont tels que décrits dans les revendications, pour son utilisation dans le traitement et/ou la prévention des infections bactériennes.
FR2003085A 2020-03-27 2020-03-27 Dérivés de nicotinamide mononucléotides dans le traitement et la prévention des infections bactériennes Active FR3108502B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR2003085A FR3108502B1 (fr) 2020-03-27 2020-03-27 Dérivés de nicotinamide mononucléotides dans le traitement et la prévention des infections bactériennes
US17/914,576 US20230210881A1 (en) 2020-03-27 2021-03-26 Nicotinamide mononucleotide derivatives for the treatment of bacterial infections
JP2022558101A JP2023526726A (ja) 2020-03-27 2021-03-26 細菌性感染症の処置のためのニコチンアミドモノヌクレオチド誘導体
PCT/EP2021/057938 WO2021191422A1 (fr) 2020-03-27 2021-03-26 Dérivés de nicotinamide mononucléotides pour le traitement des infections bactériennes
CA3171744A CA3171744A1 (fr) 2020-03-27 2021-03-26 Derives de nicotinamide mononucleotides pour le traitement des infections bacteriennes
CN202180033681.XA CN115697349A (zh) 2020-03-27 2021-03-26 用于治疗细菌感染的烟酰胺单核苷酸衍生物
AU2021245030A AU2021245030A1 (en) 2020-03-27 2021-03-26 Nicotinamide mononucleotide derivatives for the treatment of bacterial infections
EP21713440.2A EP4125929A1 (fr) 2020-03-27 2021-03-26 Dérivés de nicotinamide mononucléotides pour le traitement des infections bactériennes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2003085A FR3108502B1 (fr) 2020-03-27 2020-03-27 Dérivés de nicotinamide mononucléotides dans le traitement et la prévention des infections bactériennes
FR2003085 2020-03-27

Publications (2)

Publication Number Publication Date
FR3108502A1 FR3108502A1 (fr) 2021-10-01
FR3108502B1 true FR3108502B1 (fr) 2022-09-23

Family

ID=70614296

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2003085A Active FR3108502B1 (fr) 2020-03-27 2020-03-27 Dérivés de nicotinamide mononucléotides dans le traitement et la prévention des infections bactériennes

Country Status (8)

Country Link
US (1) US20230210881A1 (fr)
EP (1) EP4125929A1 (fr)
JP (1) JP2023526726A (fr)
CN (1) CN115697349A (fr)
AU (1) AU2021245030A1 (fr)
CA (1) CA3171744A1 (fr)
FR (1) FR3108502B1 (fr)
WO (1) WO2021191422A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022129536A1 (fr) * 2020-12-18 2022-06-23 Nuvamid Sa Dérivés de nicotinamide mononucléotide et leur utilisation dans la stimulation de l'expression de l'hémoglobine foetale

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201912267SA (en) * 2017-06-19 2020-01-30 Gangadhara Ganapati Nicotinamide riboside derivatives and their uses
US20220323477A1 (en) * 2019-09-09 2022-10-13 Nuvamid Sa Use of nmn for the prevention and/or treatment of pain, and corresponding compositions

Also Published As

Publication number Publication date
AU2021245030A1 (en) 2022-11-03
FR3108502A1 (fr) 2021-10-01
EP4125929A1 (fr) 2023-02-08
CA3171744A1 (fr) 2021-09-30
US20230210881A1 (en) 2023-07-06
WO2021191422A1 (fr) 2021-09-30
JP2023526726A (ja) 2023-06-23
CN115697349A (zh) 2023-02-03

Similar Documents

Publication Publication Date Title
FR3107897B1 (fr) Dérivés de nicotinamide mononucléotides
MA46038B1 (fr) Composés de sulfonimidoylpurinone substitués dans la position 7 pour le traitement et la prophylaxie d'infection virale
MA32231B1 (fr) Composés organiques
MA42292B1 (fr) Dérivés de sulfamoylarylamide cyclisés et leur utilisation à titre de médicaments pour le traitement de l'hépatite b
EA202190342A1 (ru) Гетеробициклические соединения для ингибирования активности shp2
MA32965B1 (fr) Derives de sulfonamides
MA41338B1 (fr) Composés de pyrazine pour le traitement de maladies infectieuses
MA42795A (fr) Composés thérapeutiques utiles pour le traitement prophylactique ou thérapeutique d'une infection par le virus du vih
EA202190116A1 (ru) Агент для профилактики или лечения спинальной мышечной атрофии
MA27990A1 (fr) Derives de piperazine pour le traitement d'infections par le vih
MA41134B1 (fr) Composés substitués de 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione pour le traitement et la prophylaxie des infections virales
MA31419B1 (fr) Derives de pyridine
TNSN07022A1 (fr) Derives de pyridine
MA42410B1 (fr) Oxystérols et leurs méthodes d'utilisation
MA32171B1 (fr) Compose heterocyclique
BRPI0518760A2 (pt) sal de potÁssio do composto, e, composiÇço farmacÊutica
MA29926B1 (fr) Derives de pyrazine
MA38315A1 (fr) Composés tétracycliques substitués par un hétérocycle et procédés pour les utiliser pour le traitement de maladies virales
ATE526341T1 (de) Makrozyklische verbindungen als antivirale mittel
MA33636B1 (fr) Dérivés aminopropioniques substitués comme inhibiteurs de néprilysine
MX2009009920A (es) Inhibidores no nucleosidos de transcriptasa inversa.
MA30932B1 (fr) Spirocetones servant d'inhibiteurs d'acetyl-coa -carboxylase
MA31873B1 (fr) Inhibiteurs de la peptide déformylase
MA49127B1 (fr) Dérivés d'indole n-substitués
MX2020011317A (es) Compuestos heterociclicos triciclicos utiles como inhibidores de la integrasa de vih.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20211001

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5